Finanical Statements
Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports 6 Months Results (in English)
Published at 17 August 2026 at 10:49Egyptian International Pharmaceuticals (EIPICO)Related stock:Egyptian International Pharmaceuticals (EIPICO) stockAll Egyptian International Pharmaceuticals (EIPICO) disclosures
Disclosure summary
Company Name : Egyptian International Pharmaceuticals (EIPICO)
ISIN Code : EGS38081C013
Currency : EGP
F/S Period : From 01/01/2026 To 30/06/2026
Net Profit : 626,674,081
F/S Period: From 01/01/2025 To 30/06/2025
Net Comparative Profit : 828,064,852
Audit Status : Reviewed
Comment : Take into consideration the minority rights
Source : Egyptian International Pharmaceuticals (EIPICO)
The Financial Statements in English (4,621 KB)
The BoD Report in English (4,916 KB)
ISIN Code : EGS38081C013
Currency : EGP
F/S Period : From 01/01/2026 To 30/06/2026
Net Profit : 626,674,081
F/S Period: From 01/01/2025 To 30/06/2025
Net Comparative Profit : 828,064,852
Audit Status : Reviewed
Comment : Take into consideration the minority rights
Source : Egyptian International Pharmaceuticals (EIPICO)
The Financial Statements in English (4,621 KB)
The BoD Report in English (4,916 KB)